Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from InhaleRx Limited ( (AU:IRX) ) is now available.
InhaleRx Limited has reported a positive cash flow from operating activities for the quarter ending June 30, 2025, amounting to $170,000, supported by government grants and tax incentives totaling $489,000. The company also secured $247,000 from financing activities, resulting in a net increase in cash and cash equivalents of $63,000 for the period, indicating a stable financial position and potential for future growth.
More about InhaleRx Limited
InhaleRx Limited operates in the healthcare industry, focusing on the development and commercialization of inhalation products. The company is primarily engaged in research and development, product manufacturing, and marketing activities related to its inhalation technologies.
Average Trading Volume: 329,510
Technical Sentiment Signal: Buy
Current Market Cap: A$8.96M
For a thorough assessment of IRX stock, go to TipRanks’ Stock Analysis page.